Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15068755 | 0.77 | RXFP1 (0.41) | RXFP1L3MBTL1APPMAPT | |
| SCHEMBL31082461 | 0.76 | RXFP1 (0.33) | RXFP1L3MBTL1KDM4EMAPTRAB9A | |
| Bromide SCHEMBL30426544 | 0.76 | RXFP1 (0.41) | RXFP1L3MBTL1APPMAPT | |
| SCHEMBL22101910 | 0.75 | ALDH1A1 (0.34) | RXFP1L3MBTL1KDM4EMAPTRAB9A | |
| SCHEMBL24033492 | 0.74 | RXFP1 (0.50) | RXFP1KDM4EMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL22235206 | 0.73 | RXFP1 (0.36) | RXFP1L3MBTL1APP | |
| SCHEMBL31210418 | 0.73 | RXFP1 (0.36) | RXFP1L3MBTL1APP | |
| SCHEMBL31082864 | 0.73 | RXFP1 (0.36) | RXFP1L3MBTL1APPMAPT | |
| SCHEMBL24033616 | 0.71 | RXFP1 (0.33) | RXFP1L3MBTL1 | |
| SCHEMBL24033549 | 0.71 | RXFP1 (0.33) | RXFP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112469707-B | Preventive or therapeutic agent for spinal muscular atrophy | 利伯纳生物科学株式会社 | 2024-06-21 | — | — | CN | disclosed |
| CN-112469707-A | Prophylactic or therapeutic agent for spinal muscular atrophy | 利伯纳生物科学株式会社 | 2021-03-09 | — | — | CN | disclosed |